Cargando…

Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy

BACKGROUND: Insufficient metabolic control during pregnancy of mothers with phenylketonuria (PKU) leads to maternal PKU syndrome, a severe embryo-/fetopathy. Since maintaining or reintroducing the strict phenylalanine (Phe) limited diet in adults with PKU is challenging, we evaluated the most import...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohde, Carmen, Thiele, Alena Gerlinde, Baerwald, Christoph, Ascherl, Rudolf Georg, Lier, Dinah, Och, Ulrike, Heller, Christina, Jung, Alexandra, Schönherr, Kathrin, Joerg-Streller, Monika, Luttat, Simone, Matzgen, Sabine, Winkler, Tina, Rosenbaum-Fabian, Stefanie, Joos, Oxana, Beblo, Skadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600879/
https://www.ncbi.nlm.nih.gov/pubmed/34794480
http://dx.doi.org/10.1186/s13023-021-02108-5
_version_ 1784601237148139520
author Rohde, Carmen
Thiele, Alena Gerlinde
Baerwald, Christoph
Ascherl, Rudolf Georg
Lier, Dinah
Och, Ulrike
Heller, Christina
Jung, Alexandra
Schönherr, Kathrin
Joerg-Streller, Monika
Luttat, Simone
Matzgen, Sabine
Winkler, Tina
Rosenbaum-Fabian, Stefanie
Joos, Oxana
Beblo, Skadi
author_facet Rohde, Carmen
Thiele, Alena Gerlinde
Baerwald, Christoph
Ascherl, Rudolf Georg
Lier, Dinah
Och, Ulrike
Heller, Christina
Jung, Alexandra
Schönherr, Kathrin
Joerg-Streller, Monika
Luttat, Simone
Matzgen, Sabine
Winkler, Tina
Rosenbaum-Fabian, Stefanie
Joos, Oxana
Beblo, Skadi
author_sort Rohde, Carmen
collection PubMed
description BACKGROUND: Insufficient metabolic control during pregnancy of mothers with phenylketonuria (PKU) leads to maternal PKU syndrome, a severe embryo-/fetopathy. Since maintaining or reintroducing the strict phenylalanine (Phe) limited diet in adults with PKU is challenging, we evaluated the most important dietary and psychosocial factors to gain and sustain good metabolic control in phenylketonuric women throughout pregnancy by a questionnaire survey with 38 questions concerning therapy feasibility. Among them, the key questions covered 5 essential items of PKU care as follows: General information about maternal PKU, PKU training, diet implementation, individual metabolic care, personal support. In addition, all participating PKU mothers were asked to estimate the quality of their personal metabolic control of the concluded pregnancies. 54 PKU mothers with 81 pregnancies were approached at 12 metabolic centers in Germany and Austria were included. According to metabolic control, pregnancies of PKU women were divided in two groups: group “ideal” (not more than 5% of all blood Phe concentrations during pregnancy > 360 µmol/l; n = 23) and group “suboptimal” (all others; n = 51). RESULTS: The demand for support was equally distributed among groups, concerning both amount and content. Personal support by the direct social environment (partner, family and friends) (“suboptimal” 71% vs “ideal” 78%) as well as individual metabolic care by the specialized metabolic center (both groups around 60%) were rated as most important factors. The groups differed significantly with respect to the estimation of the quality of their metabolic situation (p < 0.001). Group “ideal” presented a 100% realistic self-assessment. In contrast, group “suboptimal” overestimated their metabolic control in 53% of the pregnancies. Offspring of group “suboptimal” showed clinical signs of maternal PKU-syndrome in 27%. CONCLUSION: The development of training programs by specialized metabolic centers for females with PKU in child bearing age is crucial, especially since those mothers at risk of giving birth to a child with maternal PKU syndrome are not aware of their suboptimal metabolic control. Such programs should provide specific awareness training for the own metabolic situation and should include partners and families. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-02108-5.
format Online
Article
Text
id pubmed-8600879
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86008792021-11-19 Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy Rohde, Carmen Thiele, Alena Gerlinde Baerwald, Christoph Ascherl, Rudolf Georg Lier, Dinah Och, Ulrike Heller, Christina Jung, Alexandra Schönherr, Kathrin Joerg-Streller, Monika Luttat, Simone Matzgen, Sabine Winkler, Tina Rosenbaum-Fabian, Stefanie Joos, Oxana Beblo, Skadi Orphanet J Rare Dis Research BACKGROUND: Insufficient metabolic control during pregnancy of mothers with phenylketonuria (PKU) leads to maternal PKU syndrome, a severe embryo-/fetopathy. Since maintaining or reintroducing the strict phenylalanine (Phe) limited diet in adults with PKU is challenging, we evaluated the most important dietary and psychosocial factors to gain and sustain good metabolic control in phenylketonuric women throughout pregnancy by a questionnaire survey with 38 questions concerning therapy feasibility. Among them, the key questions covered 5 essential items of PKU care as follows: General information about maternal PKU, PKU training, diet implementation, individual metabolic care, personal support. In addition, all participating PKU mothers were asked to estimate the quality of their personal metabolic control of the concluded pregnancies. 54 PKU mothers with 81 pregnancies were approached at 12 metabolic centers in Germany and Austria were included. According to metabolic control, pregnancies of PKU women were divided in two groups: group “ideal” (not more than 5% of all blood Phe concentrations during pregnancy > 360 µmol/l; n = 23) and group “suboptimal” (all others; n = 51). RESULTS: The demand for support was equally distributed among groups, concerning both amount and content. Personal support by the direct social environment (partner, family and friends) (“suboptimal” 71% vs “ideal” 78%) as well as individual metabolic care by the specialized metabolic center (both groups around 60%) were rated as most important factors. The groups differed significantly with respect to the estimation of the quality of their metabolic situation (p < 0.001). Group “ideal” presented a 100% realistic self-assessment. In contrast, group “suboptimal” overestimated their metabolic control in 53% of the pregnancies. Offspring of group “suboptimal” showed clinical signs of maternal PKU-syndrome in 27%. CONCLUSION: The development of training programs by specialized metabolic centers for females with PKU in child bearing age is crucial, especially since those mothers at risk of giving birth to a child with maternal PKU syndrome are not aware of their suboptimal metabolic control. Such programs should provide specific awareness training for the own metabolic situation and should include partners and families. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-02108-5. BioMed Central 2021-11-18 /pmc/articles/PMC8600879/ /pubmed/34794480 http://dx.doi.org/10.1186/s13023-021-02108-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rohde, Carmen
Thiele, Alena Gerlinde
Baerwald, Christoph
Ascherl, Rudolf Georg
Lier, Dinah
Och, Ulrike
Heller, Christina
Jung, Alexandra
Schönherr, Kathrin
Joerg-Streller, Monika
Luttat, Simone
Matzgen, Sabine
Winkler, Tina
Rosenbaum-Fabian, Stefanie
Joos, Oxana
Beblo, Skadi
Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy
title Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy
title_full Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy
title_fullStr Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy
title_full_unstemmed Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy
title_short Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy
title_sort preventing maternal phenylketonuria (pku) syndrome: important factors to achieve good metabolic control throughout pregnancy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600879/
https://www.ncbi.nlm.nih.gov/pubmed/34794480
http://dx.doi.org/10.1186/s13023-021-02108-5
work_keys_str_mv AT rohdecarmen preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT thielealenagerlinde preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT baerwaldchristoph preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT ascherlrudolfgeorg preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT lierdinah preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT ochulrike preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT hellerchristina preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT jungalexandra preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT schonherrkathrin preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT joergstrellermonika preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT luttatsimone preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT matzgensabine preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT winklertina preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT rosenbaumfabianstefanie preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT joosoxana preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy
AT bebloskadi preventingmaternalphenylketonuriapkusyndromeimportantfactorstoachievegoodmetaboliccontrolthroughoutpregnancy